Ming Li (Memorial Sloan Kettering)

New T cell im­mune re­sponse dis­cov­ery points to 'out-of-box' can­cer ther­a­py op­tions

Re­searchers have iden­ti­fied a class of T cells with an un­con­ven­tion­al tu­mor-hom­ing mech­a­nism that could point the way to new types of can­cer im­munother­a­pies. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.